RIA Advisory Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.54M Buy
30,841
+25,281
+455% +$5.89M 1.79% 10
2025
Q4
$1.15M Buy
5,560
+3,806
+217% +$753K 0.28% 57
2025
Q3
$325K Sell
1,754
-34,767
-95% -$5.96M 0.08% 104
2025
Q2
$5.58M Buy
36,521
+794
+2% +$122K 1.64% 18
2025
Q1
$5.92M Sell
35,727
-1,617
-4% -$253K 1.93% 10
2024
Q4
$5.4M Buy
37,344
+6,308
+20% +$978K 1.84% 11
2024
Q3
$5.03M Buy
+31,036
New +$4.94M 1.78% 11
2024
Q1
$4.55M Buy
+28,756
New +$4.58M 1.84% 11
2023
Q4
Sell
-2,740
Closed -$427K 145
2023
Q3
$427K Sell
2,740
-26,783
-91% -$4.42M 0.19% 68
2023
Q2
$4.89M Buy
29,523
+954
+3% +$154K 2.1% 7
2023
Q1
$4.43M Buy
28,569
+2,486
+10% +$401K 2.04% 7
2022
Q4
$4.47M Buy
+26,083
New +$4.5M 2.59% 9

Other funds holding JNJ

RIA Advisory Group's JNJ Position: Q1 2026 in Review

RIA Advisory Group increased its Johnson & Johnson (JNJ) stake by 455% in Q1 2026, buying an estimated $5.89M and bringing the position to 30,841 shares worth $7.54M. The position accounts for 1.79% of the portfolio, ranked #10.

RIA Advisory Group first reported a position in JNJ in Q4 2022 and has held it in 12 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • RIA Advisory Group held 30,841 shares of Johnson & Johnson worth $7.54M as of Q1 2026.
  • RIA Advisory Group bought 25,281 Johnson & Johnson shares in Q1 2026, an estimated $5.89M.
  • Johnson & Johnson made up 1.79% of RIA Advisory Group's portfolio in Q1 2026, its #10 holding.
  • RIA Advisory Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 12 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on RIA Advisory Group's 13F filing for Q1 2026, filed 24 Apr 2026.